Building Inspection-Ready Systems With Digital Documentation

In pharmaceutical manufacturing, where compliance with Good Manufacturing Practice and 21 CFR Part 11 is essential, inspection readiness has evolved into a continuous expectation rather than a periodic milestone. Yet many organizations still rely on paper-based or hybrid documentation systems that create challenges in data integrity, traceability, and audit preparedness.

In this panel, experts Stephanie Wimberly of APTTMHY LLC and Piyush Modi of Amneal Pharmaceuticals discuss how digital documentation is reshaping inspection readiness. Panelists explore the role of electronic batch records, integrated quality systems, and automated workflows in supporting compliance with ALCOA+ principles, while enabling real-time visibility and faster audit response. The conversation also addressed practical challenges, including system validation, data integrity, and driving user adoption across organizations.

With perspectives aligned to regulatory expectations from agencies such as the U.S. Food and Drug Administration and European Medicines Agency, this discussion offered actionable insights on moving from reactive inspection preparation to a sustainable state of continuous readiness through digital transformation.